← Back to catalogue

dermaPACE Console

FDA UDI

Class II (US FDA UDI)

by SANUWAVE Health, Inc.

Identity

Trade Name
dermaPACE Console FDA UDI
Generic Name
Dermatological extracorporeal shock wave therapy system FDA UDI
Device Name
Energy generator and control unit ( t be used in conjuction with the PACE Applicator) for the delivery of Extracorporeal Shock Waves (ESW) for the treatment of Diabetic Foot Ulcers. FDA UDI
Model / Reference
DEP0330 FDA UDI
Description
Energy generator and control unit ( t be used in conjuction with the PACE Applicator) for the delivery of Extracorporeal Shock Waves (ESW) for the treatment of Diabetic Foot Ulcers. FDA UDI

Identifiers

Primary DI / UDI-DI
00812265010218 FDA UDI
510(k) Number
FDA Product Code
PZL FDA UDI
GMDN Term
Dermatological extracorporeal shock wave therapy system FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
878.4685 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

Yes

FDA UDI

Category: Dermatological extracorporeal shock wave therapy system

dermaPACE Console by SANUWAVE Health, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Dermatological extracorporeal shock wave therapy system.

Cleared under the same submission

DEN160037 also covers:

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI c201d920-1f57-4d79-b486-a533c5cdf2de 35 fields · synced May 30, 2026